Under construction – not a live service
Sign in
Taking people in FranceNo phase

Body Composition Measures and Recovery After Acute Stroke

Checks whether body measurements predict recovery in adults with acute stroke.

Plain-language title generated from the registry record
Registry title: Body Composition and Acute Stroke

Key facts

Where
Orléans, FranceSee the site

Where in France

  • CHU d'OrléansOrléans, FranceTaking people

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?
Print a page for my doctor

Trial details

Who runs it
Centre Hospitalier Régional d'Orléans
Trial code
NCT06589297
Record updated
2 February 2026
Original description
Body composition appears to be a prognostic factor for the severity and functional outcome of stroke patients. In this study the prognostic value of two bioimpedance parameters will be studied (skeletal mass index and phase angle) and two temporal muscle measurements (thickness and surface area) to predict the functional outcome of patients at discharge and at 6 monthsRead full original descriptionShow less

Prognostic Value for Predicting Functional Outcome Bioimpedancemetry and Temporal Muscle Measurement in Acute Stroke

Body composition appears to be a prognostic factor for the severity and functional outcome of stroke patients. In this study the prognostic value of two bioimpedance parameters will be studied (skeletal mass index and phase angle) and two temporal muscle measurements (thickness and surface area) to predict the functional outcome of patients at discharge and at 6 months

Inclusion: volunteer stroke patients in acute phase; Age ≥ 18 years; Having had a brain MRI; Able to understand assessment guidelines; Not having objected to participate in the study after being duly informed.

Exclusion: Person under tutorship or curatorship; Person under court protection; Persons deprived of their liberty; Pregnant or breastfeeding women; Have a pacemaker or defibrillator.

ClinicalTrials.gov NCT06589297